KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Accumulated Expenses (2018 - 2025)

ClearPoint Neuro's Accumulated Expenses history spans 13 years, with the latest figure at $3.5 million for Q3 2025.

  • For Q3 2025, Accumulated Expenses fell 3.27% year-over-year to $3.5 million; the TTM value through Sep 2025 reached $3.5 million, down 3.27%, while the annual FY2024 figure was $4.9 million, 65.76% up from the prior year.
  • Accumulated Expenses for Q3 2025 was $3.5 million at ClearPoint Neuro, up from $2.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $4.9 million in Q4 2024 and bottomed at $990000.0 in Q1 2021.
  • The 5-year median for Accumulated Expenses is $2.3 million (2023), against an average of $2.4 million.
  • The largest annual shift saw Accumulated Expenses surged 65.76% in 2024 before it dropped 3.27% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $2.6 million in 2021, then increased by 8.45% to $2.8 million in 2022, then rose by 4.36% to $2.9 million in 2023, then skyrocketed by 65.76% to $4.9 million in 2024, then dropped by 28.02% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Accumulated Expenses are $3.5 million (Q3 2025), $2.9 million (Q2 2025), and $1.9 million (Q1 2025).